LAMISIL

Medicinal product

(Invented) name

LAMISIL

Active substance (s)

Terbinafino hidrochloridas

Strength

10 mg/g

Pharmaceutical form

kremas

Route (s) of administration

vartoti ant odos

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D01AE15, Terbinafine

Marketing authorisation holder

Karo Healthcare AB, Švedija

Date of authorisation

1994-03-31

Date of renewal

2012-08-10

Documents

0101 LAMISIL kremas II PL 2024 09 30.docx

0101 Pakuotės lapelis 2024 09 30.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 g kremo yra	1 g
Terbinafino hidrochloridas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
15923	20019	1020019	tūbelė	15 g N1		Nereceptinis	LT/1/94/0101/002	Netiekiama	2025-10-06	2025-12-12	No	-	-	Download

Stadijos

Data	Stadija
2012-08-10	Perregistruotas
1994-03-31	Registruotas